
Precision medicines for the microbiome
What they do: Develop in vivo gene-editing medicines that target bacterial genes in the human microbiome (Eligobiotics, GEM).
Headquarters: Paris, France
Founding team: Founded by Luciano Marraffini, Timothy Lu, David Bikard and Xavier Duportet
Recent funding: Series B announced Dec 5, 2023 (led by Sanofi Ventures); total funding reported $74.7M
Employee count: About 30
Therapeutic modulation of the human microbiome via in vivo bacterial gene editing
Biotechnology
30000000
Series B announced Dec 5, 2023; participants included Bpifrance, Khosla Ventures and Seventure Partners.
20000000
5000000
France 2030 government grant for a topical gene-delivery platform; company reported expansion of Series B to $35M in this announcement.
“Led by Sanofi Ventures in Series B; recurring participation from Khosla Ventures and Seventure Partners”
Company Name: Eligo Bioscience
Location: Paris, France
Employment Type: Full-time
Department: unspecified
Eligo Bioscience, backed by top-tier investors from Silicon Valley and Europe, is pioneering next-generation microbiome therapeutics. Co-founded by MIT and Rockefeller University scientists, Eligo is headquartered in Paris, France. Our mission is to address unmet medical needs in inflammatory and infectious diseases, as well as oncology, through groundbreaking gene-editing medicines.
Our first-in-class synthetic biology platform has earned Eligo numerous international awards and recognition, including being named one of the World Economic Forum’s “30 Most Innovative Companies” and has been featured in international press such as Nature, Science, The Economist, BBC, and The New York Times.
More recently, our latest work was published in Nature this summer (In situ targeted base editing of bacteria in the mouse gut).
Organization Context: Why Join Us?
Job Title: Senior In-Vivo Scientist – Microbiologist
Location: Paris, France
Employment Type: Full-time
As part of the Host-Microbiome interactions team, you will contribute to the generation of pivotal preclinical data to support the development of Eligo’s programs towards the clinic, and to discovery work supporting the entry of new programs into Eligo's portfolio. You will report to the Senior Director of Host-Microbiome interactions.
Technical Skills
Other Skills
If you’re excited to work at the forefront of synthetic biology and gene-editing, in a role that combines scientific rigor with collaborative teamwork, we’d love to hear from you!